Free Trial

The Clorox Company (NYSE:CLX) Stock Position Lifted by Candriam S.C.A.

Clorox logo with Consumer Staples background
Remove Ads

Candriam S.C.A. lifted its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 16.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,376 shares of the company's stock after purchasing an additional 2,179 shares during the quarter. Candriam S.C.A.'s holdings in Clorox were worth $2,497,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Mizuho Securities USA LLC raised its position in Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company's stock worth $733,095,000 after acquiring an additional 4,490,421 shares in the last quarter. Ilex Capital Partners UK LLP increased its stake in shares of Clorox by 512.7% during the 3rd quarter. Ilex Capital Partners UK LLP now owns 542,110 shares of the company's stock worth $88,315,000 after purchasing an additional 453,624 shares in the last quarter. Assenagon Asset Management S.A. raised its holdings in shares of Clorox by 302.0% in the fourth quarter. Assenagon Asset Management S.A. now owns 353,367 shares of the company's stock worth $57,390,000 after acquiring an additional 265,455 shares during the last quarter. State Street Corp lifted its position in shares of Clorox by 3.1% in the third quarter. State Street Corp now owns 8,182,109 shares of the company's stock valued at $1,332,947,000 after acquiring an additional 245,525 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in shares of Clorox during the fourth quarter valued at $37,935,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on CLX shares. StockNews.com downgraded shares of Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. DA Davidson dropped their price objective on Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a report on Wednesday, February 5th. JPMorgan Chase & Co. lifted their target price on Clorox from $171.00 to $173.00 and gave the company a "neutral" rating in a report on Tuesday, February 4th. Evercore ISI upped their price target on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Finally, Barclays boosted their target price on Clorox from $130.00 to $140.00 and gave the stock an "underweight" rating in a report on Wednesday, February 5th. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $159.62.

Check Out Our Latest Report on Clorox

Clorox Stock Down 0.5 %

NYSE:CLX traded down $0.71 on Thursday, reaching $146.79. The stock had a trading volume of 1,395,212 shares, compared to its average volume of 1,220,275. The company has a 50-day moving average of $154.81 and a 200 day moving average of $160.32. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The stock has a market cap of $18.08 billion, a P/E ratio of 40.11, a price-to-earnings-growth ratio of 2.62 and a beta of 0.45. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the prior year, the company earned $2.16 earnings per share. On average, research analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.32%. Clorox's dividend payout ratio is presently 133.33%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads